Free Trial
Seamus Fernandez

Seamus Fernandez Analyst Performance

Senior Managing Director and Equity Research Analyst at Guggenheim

Seamus Fernandez is a stock analyst at Guggenheim focused in the healthcare sector, covering 32 publicly traded companies. Over the past year, Seamus Fernandez has issued 52 stock ratings, including strong buy, buy, and hold recommendations. While full access to Seamus Fernandez's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Seamus Fernandez's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
139 Last 11 Years
Buy Recommendations
82.61% 114 Buy Ratings
Companies Covered
32 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy1.4%2 ratings
Buy81.2%112 ratings
Hold17.4%24 ratings
Sell0.0%0 ratings

Out of 138 total stock ratings issued by Seamus Fernandez at Guggenheim, the majority (81.2%) have been Buy recommendations, followed by 17.4% Hold and 1.4% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
78.1% of companies on NASDAQ
25 companies
NYSE
21.9% of companies on NYSE
7 companies

Seamus Fernandez, an analyst at Guggenheim, currently covers 32 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
31 companies
96.9%
Miscellaneous
1 company
3.1%

Seamus Fernandez of Guggenheim specializes in stock coverage within the Healthcare sector, with additional focus on companies.

Coverage Industries

IndustryPercentage
PHARMACEUTICALS
16 companies
50.0%
BIOTECHNOLOGY
15 companies
46.9%
Miscellaneous
1 company
3.1%

About Seamus Fernandez

Mr. Fernandez is a Senior Managing Director and Equity Research Analyst covering the Global Biopharmaceutical and Biotechnology sectors. Mr. Fernandez has more than 20 years of experience in the healthcare industry. Prior to joining Guggenheim, he was at LEERINK Partners, where he was a Managing Director and Senior Equity Research Analyst covering Pharmaceutical and Biotechnology companies. Previously, he was a Vice President at Cowen & Company. Mr. Fernandez earned his B.A. in Chemistry from Williams College in 1995.
Follow on LinkedIn

Seamus Fernandez's Ratings History at Guggenheim

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
11/9/2026Initiated Coverage$14.50$42.00Buy
Septerna, Inc. stock logo
SEPN
Septerna
11/6/2026Boost Price Target$49.37$65.00Buy
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
11/5/2026Boost Price Target$106.04$147.00Buy
Retension Pharmaceuticals, Inc. stock logo
RTSN
Retension Pharmaceuticals
11/2/2026Initiated Coverage$11.36$55.00Buy
Arcutis Biotherapeutics, Inc. stock logo
ARQT
Arcutis Biotherapeutics
10/19/2026Boost Price Target$30.93$44.00Buy
Vaxcyte, Inc. stock logo
PCVX
Vaxcyte
10/5/2026Boost Price Target$56.48$125.00Buy
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
10/2/2026Boost Price Target$9.37$26.00Buy
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
10/2/2026Boost Price Target$56.55$150.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
9/18/2026Boost Price Target$1,152.13$1,284.00Buy
Inventiva S.A. Sponsored ADR stock logo
IVA
Inventiva
9/15/2026Boost Price Target$3.88$14.00Buy
Tenax Therapeutics, Inc. stock logo
TENX
Tenax Therapeutics
8/31/2026Downgrade$2.13Neutral
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
8/27/2026Boost Price Target$37.29$57.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
8/19/2026Boost Price Target$36.28$55.00Buy
Septerna, Inc. stock logo
SEPN
Septerna
8/11/2026Boost Price Target$38.85$51.00Buy
Tenax Therapeutics, Inc. stock logo
TENX
Tenax Therapeutics
8/11/2026Set Price Target$1.38$4.00Buy
Tenax Therapeutics, Inc. stock logo
TENX
Tenax Therapeutics
8/11/2026Reiterated Rating$1.38$4.00Buy
Arcutis Biotherapeutics, Inc. stock logo
ARQT
Arcutis Biotherapeutics
8/6/2026Boost Price Target$27.10$38.00Buy
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
7/31/2026Reiterated Rating$64.98$75.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
7/13/2026Boost Price Target$1,189.06$1,273.00Buy
Septerna, Inc. stock logo
SEPN
Septerna
7/1/2026Lower Price Target$33.49$45.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
6/25/2026Boost Price Target$17.75$40.00Buy
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
6/23/2026Downgrade$132.65Neutral
Tenax Therapeutics, Inc. stock logo
TENX
Tenax Therapeutics
6/22/2026Reiterated Rating$12.00$40.00Buy
Avalyn Pharma Inc. stock logo
AVLN
Avalyn Pharma
5/25/2026Initiated Coverage$28.84$80.00Buy
Avalyn Pharma Inc. stock logo
AVLN
Avalyn Pharma
5/25/2026Upgrade$26.70Strong-Buy
Aclaris Therapeutics, Inc. stock logo
ACRS
Aclaris Therapeutics
5/5/2026Initiated Coverage$4.53$12.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
5/5/2026Reiterated Rating$967.49$1,183.00Buy
Aclaris Therapeutics, Inc. stock logo
ACRS
Aclaris Therapeutics
5/4/2026Upgrade$4.75Strong-Buy
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
4/29/2026Lower Price Target$8.52$25.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
4/21/2026Boost Price Target$907.66$1,183.00Buy
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
4/8/2026Reiterated Rating$57.68$72.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
3/30/2026Lower Price Target$894.78$1,163.00Buy
Generate Biomedicines Inc stock logo
GENB
Generate Biomedicines
3/24/2026Initiated Coverage$12.52$30.00Buy
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
3/24/2026Boost Price Target$79.24$160.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
3/19/2026Boost Price Target$13.80$30.00Buy
Tenax Therapeutics, Inc. stock logo
TENX
Tenax Therapeutics
3/16/2026Boost Price Target$13.84$34.00Buy
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
2/27/2026Boost Price Target$98.07$143.00Buy
Arcutis Biotherapeutics, Inc. stock logo
ARQT
Arcutis Biotherapeutics
2/27/2026Boost Price Target$27.59$35.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2/26/2026Boost Price Target$1,012.89$1,168.00Buy
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
2/6/2026Reiterated Rating$59.43$72.00Buy
My $247 scanner for $7 (Ad)

Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel

Get the Instant Scanner for $7 in the Black Friday sale today.
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
2/3/2026Initiated Coverage$6.23$27.00Buy
Vaxcyte, Inc. stock logo
PCVX
Vaxcyte
2/2/2026Reiterated Rating$55.10$116.00Buy
Structure Therapeutics Inc. Sponsored ADR stock logo
GPCR
Structure Therapeutics
1/20/2026Boost Price Target$88.64$140.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1/20/2026Lower Price Target$1,035.53$1,161.00Buy
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
1/16/2026Boost Price Target$40.91$88.00Buy
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
12/23/2025Reiterated Rating$54.68Buy
Tenax Therapeutics, Inc. stock logo
TENX
Tenax Therapeutics
12/17/2025Reiterated Rating$11.16$25.00Buy
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
12/17/2025Boost Price Target$112.45$140.00Buy
Sanofi stock logo
SNY
Sanofi
12/9/2025Downgrade$48.44Neutral
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
12/3/2025Reiterated Rating$1,045.50$1,163.00Buy
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
11/18/2025Downgrade$217.91Hold
Inventiva S.A. Sponsored ADR stock logo
IVA
Inventiva
11/18/2025Lower Price Target$4.04$11.00Buy
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
11/10/2025Lower Price Target$24.32$77.00Buy
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
10/22/2025Downgrade$23.16Neutral
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
10/16/2025Reiterated Rating$826.20$948.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
10/8/2025Boost Price Target$844.30$948.00Buy
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
9/24/2025Set Price Target$90.44$167.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
9/15/2025Boost Price Target$11.65$25.00Buy
Tenax Therapeutics, Inc. stock logo
TENX
Tenax Therapeutics
8/14/2025Lower Price Target$5.84$14.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
8/13/2025Lower Price Target$647.26$875.00Buy
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
8/8/2025Reiterated Rating$62.00Buy
Structure Therapeutics Inc. Sponsored ADR stock logo
GPCR
Structure Therapeutics
8/7/2025Lower Price Target$16.18$90.00Buy
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
8/6/2025Boost Price Target$89.85$120.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
7/11/2025Boost Price Target$790.23$942.00Buy
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
7/9/2025Set Price Target$49.41$69.00
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
7/2/2025Reiterated Rating$44.26$116.00Buy
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
6/24/2025Initiated Coverage$5.02$17.00Buy
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
6/24/2025Set Price Target$44.95$68.00Buy
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
6/20/2025Reiterated Rating$757.47$936.00Buy
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
5/16/2025Boost Price Target$24.01$50.00Buy
Tenax Therapeutics, Inc. stock logo
TENX
Tenax Therapeutics
5/15/2025Reiterated Rating$5.89$15.00Buy
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
5/14/2025Set Price Target$15.35$48.00Buy
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
5/9/2025Boost Price Target$19.04$35.00Buy
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
4/17/2025Downgrade$59.89Hold
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
4/14/2025Lower Price Target$743.92$928.00Buy
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
4/10/2025Reiterated Rating$6.35$44.00Buy
Arcutis Biotherapeutics, Inc. stock logo
ARQT
Arcutis Biotherapeutics
4/3/2025Reiterated Rating$15.71Buy
Vaxcyte, Inc. stock logo
PCVX
Vaxcyte
3/12/2025Reiterated Rating$72.86$160.00Buy
Vaxcyte, Inc. stock logo
PCVX
Vaxcyte
2/26/2025Reiterated Rating$82.18$160.00Buy
Arcutis Biotherapeutics, Inc. stock logo
ARQT
Arcutis Biotherapeutics
2/24/2025Reiterated Rating$12.81Buy
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
2/24/2025Reiterated Rating$9.27Buy
Arcutis Biotherapeutics, Inc. stock logo
ARQT
Arcutis Biotherapeutics
2/10/2025Reiterated Rating$11.25Buy
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
2/10/2025Reiterated Rating$39.22Buy